"The comment in the second last paragraph about the effects on Long COVID taking months or years to prove is a little scary for us as that was in the description of what our PIII trial is about."

As stated by Dr. Barry S. Zingman, a member of Resverlogix's COVID -19 Scientific Advisory Board, (made up of 6 members) in the May 9th news report, they already understand the seriousness, of the long-term, cardiovascular consequences of the COVID-19 pandemic. If they already know the consequences this quickly, surely it should not take that long to determine if Apabetalone is a benefit or not. Besides Phase 3 will take several months if not a couple of years to complete.